Invex Therapeutics Ltd (ASX:IXC)
Australia · Delayed Price · Currency is AUD 0.1600
0.00 (0.00%)
Sep 23, 2025, 10:38 AM AEST
Invex Therapeutics Market Cap
Invex Therapeutics has a market cap or net worth of 12.02 million as of September 26, 2025. Its market cap has increased by 97.53% in one year.
Market Cap
12.02M
Enterprise Value
6.65M
Revenue
229.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 12.02M, a decrease of -79.66%. That is a compound annual growth rate of -22.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2025 | 12.02M | 142.42% |
| Dec 23, 2024 | 4.96M | -18.52% |
| Dec 27, 2023 | 6.09M | -85.14% |
| Dec 28, 2022 | 40.96M | -22.70% |
| Dec 31, 2021 | 52.98M | -1.40% |
| Dec 31, 2020 | 53.74M | 13.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 95.78B |
| Pro Medicus | 31.54B |
| Cochlear | 18.31B |
| Sonic Healthcare | 10.45B |
| Ramsay Health Care | 7.31B |
| Telix Pharmaceuticals | 5.03B |
| Ansell | 4.57B |
| Mesoblast | 3.19B |